Heinzel, Andreas
EmergenTec (Austria)
2 papers on CoChatORCID 0000-0002-8447-1795
Most cited papers
- Verified
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A., & Mayer, G. (2019) · Diabetologia
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 457
- Verified
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy
Fechete, R., Heinzel, A., Perco, P., Mönks, K., Söllner, J., Stelzer, G., Eder, S., Lancet, D., Oberbauer, R., Mayer, G., et al. (2011) · PROTEOMICS – Clinical Applications
Bioinformatics and Genomic NetworksChronic Kidney Disease and Diabetes
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free